Cargando…

(18)F-sodium fluoride PET-CT visualizes both axial and peripheral new bone formation in psoriatic arthritis patients

PURPOSE: As bone formation is associated with psoriatic arthritis (PsA), positron emission tomography (PET) using a (18)F-Fluoride tracer may enable sensitive detection of disease activity. Our primary aim was to determine the feasibility of whole-body (18)F-sodium fluoride PET-CT in clinically acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jongh, Jerney, Hemke, Robert, Zwezerijnen, Gerben J. C., Yaqub, Maqsood, van der Horst-Bruinsma, Irene E., van de Sande, Marleen G. H., van Kuijk, Arno W. R., Voskuyl, Alexandre E., van der Laken, Conny J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852163/ https://www.ncbi.nlm.nih.gov/pubmed/36370181 http://dx.doi.org/10.1007/s00259-022-06035-w

Ejemplares similares

[(18)F]Fluoride PET provides distinct information on disease activity in ankylosing spondylitis as compared to MRI and conventional radiography
por: de Jongh, Jerney, et al.
Publicado: (2022)

Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET
por: Verweij, Nicki, et al.
Publicado: (2022)

Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation
por: Broens, Bo, et al.
Publicado: (2022)

Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six‐Month Results of a Placebo‐Controlled Trial
por: Rusman, Tamara, et al.
Publicado: (2021)

Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice
por: van Mens, Leonieke J. J., et al.
Publicado: (2017)

The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients
por: Peelen, Daphne M, et al.
Publicado: (2020)

Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky
por: Rusman, T., et al.
Publicado: (2018)

Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis
por: Steinz, Maarten M., et al.
Publicado: (2022)

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by (18)F-fluoride positron emission tomography
por: Bruijnen, Stefan T G, et al.
Publicado: (2018)

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by (18)F-fluoride positron emission tomography
por: Bruijnen, Stefan T G, et al.
Publicado: (2018)

Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study
por: Bruijnen, Stefan TG, et al.
Publicado: (2012)

Sex and gender differences in axial spondyloarthritis: myths and truths
por: Rusman, Tamara, et al.
Publicado: (2020)

Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [(11)C]DPA-713 Positron Emission Tomography
por: Yaqub, Maqsood, et al.
Publicado: (2020)

Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis
por: Khodadust, Fatemeh, et al.
Publicado: (2022)

Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis
por: Bolt, Janne W., et al.
Publicado: (2022)

Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data
por: Van Kuijk, Arno W R, et al.
Publicado: (2023)

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
por: de Jong, Henriëtte M. Y., et al.
Publicado: (2019)

Synovitis in Psoriatic Arthritis: Immunohistochemistry, Comparisons With Rheumatoid Arthritis, and Effects of Therapy
por: van Kuijk, Arno W. R., et al.
Publicado: (2011)

First in man study of [(18)F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis
por: Verweij, Nicki J. F., et al.
Publicado: (2020)

Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study
por: Gent, Yoony Y. J., et al.
Publicado: (2015)

Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis
por: Agca, Rabia, et al.
Publicado: (2021)

Translational Research Studies Unraveling the Origins of Psoriatic Arthritis: Moving Beyond Skin and Joints
por: Bolt, Janne W., et al.
Publicado: (2021)

Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

Corrigendum: Translational Research Studies Unraveling the Origins of Psoriatic Arthritis: Moving Beyond Skin and Joints
por: Bolt, Janne W., et al.
Publicado: (2021)

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
por: de Jong, Tamarah D, et al.
Publicado: (2015)

Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort
por: de Winter, Janneke J., et al.
Publicado: (2018)

Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis
por: de Winter, Janneke J, et al.
Publicado: (2019)

Mucosal-associated invariant T cells in patients with axial spondyloarthritis
por: van der Meer, Rienk Gerben, et al.
Publicado: (2023)

B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
por: Bruijnen, Stefan, et al.
Publicado: (2016)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body (18)F-Fluorodeoxyglucose and (89)Zr-Rituximab PET Scans
por: de Vries, Bart M., et al.
Publicado: (2022)

Early Disease Activity or Clinical Response as Predictors of Long‐Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
por: van der Heijde, D., et al.
Publicado: (2017)

Targeted Therapies in Axial Psoriatic Arthritis
por: Floris, Alberto, et al.
Publicado: (2021)

MRI Findings in Axial Psoriatic Spondylarthritis
por: Pascu, Loredana Sabina, et al.
Publicado: (2023)

In Vivo Imaging of Inflammation and Infection 2019
por: Roivainen, Anne, et al.
Publicado: (2020)

Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
por: Benavent, Diego, et al.
Publicado: (2020)

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation
por: Hernandez Alava, Monica, et al.
Publicado: (2022)

Variability in quantitative analysis of atherosclerotic plaque inflammation using (18)F-FDG PET/CT
por: Lensen, Karel-Jan D. F., et al.
Publicado: (2017)

Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts
por: de Hooge, Manouk, et al.
Publicado: (2023)

Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review
por: van der Horst-Bruinsma, Irene E., et al.
Publicado: (2022)

Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial
por: Michielsens, Celia A. J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c86ce8vdh8beqcmg878vklaj7r